Cross-cultural adaptation of motivational interviewing for use in rural Nepal

Background

Motivational Interviewing (MI) has a robust evidence base in facilitating behavior change for several health conditions. MI focuses on the individual and assumes patient autonomy. Cross-cultural adaptation can face several challenges in settings where individualism and autonomy may not be as prominent. Sociocultural factors such as gender, class, caste hinder individual decision-making. Key informant perspectives are an essential aspect of cross-cultural adaptation of new interventions. Here, we share our experience of translating and adapting MI concepts to the local language and culture in rural Nepal, where families and communities play a central role in influencing a person’s behaviors.

Methods

We developed, translated, field-tested, and adapted a Nepali MI training module with key informants to generate insights on adapting MI for the first time in this cultural setting. Key informants were five Nepali nurses who supervise community health workers. We used structured observation notes to describe challenges and experiences in cross-cultural adaptation. We conducted this study as part of a larger study on using MI to improve adherence to HIV treatment.

Results

Participants viewed MI as an effective intervention with the potential to assist patients poorly engaged in care. Regarding patient autonomy, they initially shared examples of family members unsuccessfully dictating patient behavior change. These discussions led to consensus that every time the family members restrict patient's autonomy, the patient complies temporarily but then resumes their unhealthy behavior. In addition, participants highlighted that even when a patient is motivated to change (e.g., return for follow-up), their family members may not “allow” it. Discussion led to suggestions that health workers may need to conduct MI separately with patients and family members to understand everyone’s motivations and align those with the patient’s needs.

Conclusions

MI carries several cultural assumptions, particularly around individual freedom and autonomy. MI adaptation thus faces challenges in cultures where such assumptions may not hold. However, cross-cultural adaptation with key informant perspectives can lead to creative strategies that recognize both the patient’s autonomy and their role as a member of a complex social fabric to facilitate behavior change.

Development of a muffler for control of noise pollution in a diesel engine

The present work aims at controlling the noise level of a diesel engine by developing an exhaust muffler for the same, since exhaust noise is the single largest contributor to the overall noise from the engine. The TATA 1210 six-cylinder diesel engine was considered for test purposes. A simulated design, developed by Ricardo with the application of the engine performance simulation program WAVE, was taken up, and this was modified in certain aspects to suit the engine under consideration. The muffler was fabricated and data were recorded for evaluation of the acoustic performance as well as the engine performance and for purposes of comparison with the existing muffler as well as with the open-ended exhaust system. The new muffler was found to be superior to the existing one in terms of both acoustic performance and engine performance. With the new muffler, the maximum noise reduction obtained was 19.3 dB(A) and the maximum brake thermal efficiency obtained was 39 per cent, while with the existing muffler the corresponding values were 14.5 dB(A)and 37.4 per cent. The present work has thus experimentally shown that results from WAVE can be modified and applied to an alternative design.

The results of surgical management of displaced tibial plateau fractures in the elderly

We retrospectively reviewed 32 elderly patients (mean age 71.7 years, range 66-83 years) with displaced tibial plateau fractures after a mean of 3.7 years (range 1-7 years) after operative treatment. Schatzker type 2 fracture was the commonest pattern of fracture (60.3 per cent). According to the modified Rasmussen clinical and radiographic criteria, there were nine excellent, 14 good, five fair and four poor results clinically, and 11 excellent, 12 good, six fair and three poor results radiographically. There was no significant correlation between the final radiographic appearance and clinical outcome. Fourteen patients mobilized postoperatively on a continuous passive motion machine followed by a cast brace had a better result than those mobilized in a cast brace alone, but the difference was not statistically significant (P = 0.29). Postoperative complications included deep vein thrombosis in two patients.

Differential response of testis and serum gonadotropins to testosterone in rats treated with a gonadotropin releasing hormone antagonist or estradiol 17 beta

Adult rats treated with a GnRH antagonist (Ac D2Nal1, D4Cl Phe2, DTrp3, DArg6, DAla10 GnRH; code: 103-289-10, National Institutes of Health, USA) for 5 weeks (250 micrograms/kg b.w) showed multiple degrees of impairment and atrophy of the genital organs concomitant with decreased serum levels of testosterone, LH and FSH. Inhibition of spermatogenesis was characterized by germ cell degeneration and overall decline in different cell numbers and in particular, spermatids of any kind were completely absent. Testosterone supplementation (60 micrograms/rat/day, sc) to GnRH antagonist treated rats, for the same period, significantly elevated the weights of the sex organs, and the serum levels of hormones. Spermatogenesis was improved both qualitatively and quantitatively; albeit failed to be restored back to control levels. Treatment with estradiol 17 beta (1 microgram/rat/day) for 5 weeks had insignificant effect on spermatogenesis but the weights of the genital organs (seminal vesicles by 19% and ventral prostate by 40%) and the levels of serum hormones (LH by 24%, FSH 22% and testosterone by 25%) were otherwise reduced. Administration of testosterone either alone or in combination with estradiol 17 beta had only a marginal effect on spermatogenesis or on other reproductive parameters. The results indicate a positive shift in the response of the testis and serum levels of gonadotropins to testosterone supplementation in rats treated with either GnRH antagonist or estradiol 17 beta.